D.E. Shaw & Co
EW icon

D.E. Shaw & Co’s Edwards Lifesciences EW Stock Holding History

D.E. Shaw & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,700
Closed -$558K – 4448
2025
Q1 		$558K Buy
+7,700
New +$551K ﹤0.01% 3446
2024
Q3 		– Sell
-9,600
Closed -$887K – 4627
2024
Q2 		$887K Buy
+9,600
New +$850K ﹤0.01% 3269
2021
Q1 		– Sell
-102,900
Closed -$9.39M – 4169
2020
Q4 		$9.39M Hold
102,900
– – 0.01% 1421
2020
Q3 		$8.21M Sell
102,900
-30,000
-23% -$2.34M 0.01% 1370
2020
Q2 		$9.19M Hold
132,900
– – 0.01% 1236
2020
Q1 		$8.36M Sell
132,900
-17,700
-12% -$1.28M 0.01% 1099
2019
Q4 		$11.7M Buy
150,600
+10,800
+8% +$843K 0.01% 1105
2019
Q3 		$10.2M Buy
139,800
+60,000
+75% +$4.21M 0.01% 1143
2019
Q2 		$4.91M Hold
79,800
– – 0.01% 1601
2019
Q1 		$5.09M Buy
+79,800
New +$4.55M 0.01% 1541
2018
Q1 		– Sell
-30,000
Closed -$1.13M – 3573
2017
Q4 		$1.13M Hold
30,000
– – ﹤0.01% 2509
2017
Q3 		$1.09M Hold
30,000
– – ﹤0.01% 2438
2017
Q2 		$1.18M Hold
30,000
– – ﹤0.01% 2306
2017
Q1 		$941K Hold
30,000
– – ﹤0.01% 2333
2016
Q4 		$937K Hold
30,000
– – ﹤0.01% 2498
2016
Q3 		$1.21M Buy
+30,000
New +$1.13M ﹤0.01% 2281
2016
Q1 		– Sell
-240,000
Closed -$6.32M – 3525
2015
Q4 		$6.32M Hold
240,000
– – 0.01% 1249
2015
Q3 		$5.69M Hold
240,000
– – 0.01% 1310
2015
Q2 		$5.7M Hold
240,000
– – 0.01% 1364
2015
Q1 		$5.7M Hold
240,000
– – 0.01% 1295
2014
Q4 		$5.09M Buy
240,000
+180,000
+300% +$3.62M 0.01% 1554
2014
Q3 		$1.02M Buy
+60,000
New +$947K ﹤0.01% 2795
2013
Q4 		– Sell
-37,200
Closed -$432K – 4522
2013
Q3 		$432K Buy
+37,200
New +$435K ﹤0.01% 3675

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

D.E. Shaw & Co's EW Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 89,515 shares — an estimated $7.63M sold.

D.E. Shaw & Co first reported a position in EW in Q2 2013 and held it in 45 quarters. The position peaked at $251M in Q1 2023. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 89,515 Edwards Lifesciences shares in Q1 2026, an estimated $7.63M.
  • D.E. Shaw & Co first reported a position in Edwards Lifesciences in Q2 2013 and held it in 45 quarters.
  • D.E. Shaw & Co's Edwards Lifesciences position peaked at $251M in Q1 2023.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.